Does the dopamine hypothesis explain schizophrenia?

Chi Ieong Lau, Han Cheng Wang, Rong-Long Shiu, Mu En Liu

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The dopamine hypothesis has been the cornerstone in the research and clinical practice of schizophrenia. With the initial emphasis on the role of excessive dopamine, the hypothesis has evolved to a concept of combining prefrontal hypodopaminergia and striatal hyperdopaminergia, and subsequently to the present aberrant salience hypothesis. This article provides a brief overview of the development and evidence of the dopamine hypothesis. It will argue that the current model of aberrant salience explains psychosis in schizophrenia and provides a plausible linkage between the pharmacological and cognitive aspects of the disease. Despite the privileged role of dopamine hypothesis in psychosis, its pathophysiological rather than etiological basis, its limitations in defining symptoms other than psychosis, as well as the evidence of other neurotransmitters such as glutamate and adenosine, prompt us to a wider perspective of the disease. Finally, dopamine does explain the pathophysiology of schizophrenia, but not necessarily the cause per se. Rather, dopamine acts as the common final pathway of a wide variety of predisposing factors, either environmental, genetic, or both, that lead to the disease. Other neurotransmitters, such as glutamate and adenosine, may also collaborate with dopamine to give rise to the entire picture of schizophrenia.

Original languageEnglish
Pages (from-to)389-400
Number of pages12
JournalReviews in the Neurosciences
Volume24
Issue number4
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Dopamine
Schizophrenia
Psychotic Disorders
Adenosine
Neurotransmitter Agents
Glutamic Acid
Corpus Striatum
Causality
Pharmacology
Research

Keywords

  • Aberrant salience
  • Dopamine
  • Dopamine hypothesis
  • Psychosis
  • Schizophrenia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Does the dopamine hypothesis explain schizophrenia? / Lau, Chi Ieong; Wang, Han Cheng; Shiu, Rong-Long; Liu, Mu En.

In: Reviews in the Neurosciences, Vol. 24, No. 4, 08.2013, p. 389-400.

Research output: Contribution to journalArticle

Lau, Chi Ieong ; Wang, Han Cheng ; Shiu, Rong-Long ; Liu, Mu En. / Does the dopamine hypothesis explain schizophrenia?. In: Reviews in the Neurosciences. 2013 ; Vol. 24, No. 4. pp. 389-400.
@article{9e6e5e49ec6c457888affe2de1bb90b6,
title = "Does the dopamine hypothesis explain schizophrenia?",
abstract = "The dopamine hypothesis has been the cornerstone in the research and clinical practice of schizophrenia. With the initial emphasis on the role of excessive dopamine, the hypothesis has evolved to a concept of combining prefrontal hypodopaminergia and striatal hyperdopaminergia, and subsequently to the present aberrant salience hypothesis. This article provides a brief overview of the development and evidence of the dopamine hypothesis. It will argue that the current model of aberrant salience explains psychosis in schizophrenia and provides a plausible linkage between the pharmacological and cognitive aspects of the disease. Despite the privileged role of dopamine hypothesis in psychosis, its pathophysiological rather than etiological basis, its limitations in defining symptoms other than psychosis, as well as the evidence of other neurotransmitters such as glutamate and adenosine, prompt us to a wider perspective of the disease. Finally, dopamine does explain the pathophysiology of schizophrenia, but not necessarily the cause per se. Rather, dopamine acts as the common final pathway of a wide variety of predisposing factors, either environmental, genetic, or both, that lead to the disease. Other neurotransmitters, such as glutamate and adenosine, may also collaborate with dopamine to give rise to the entire picture of schizophrenia.",
keywords = "Aberrant salience, Dopamine, Dopamine hypothesis, Psychosis, Schizophrenia",
author = "Lau, {Chi Ieong} and Wang, {Han Cheng} and Rong-Long Shiu and Liu, {Mu En}",
year = "2013",
month = "8",
doi = "10.1515/revneuro-2013-0011",
language = "English",
volume = "24",
pages = "389--400",
journal = "Reviews in the Neurosciences",
issn = "0334-1763",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "4",

}

TY - JOUR

T1 - Does the dopamine hypothesis explain schizophrenia?

AU - Lau, Chi Ieong

AU - Wang, Han Cheng

AU - Shiu, Rong-Long

AU - Liu, Mu En

PY - 2013/8

Y1 - 2013/8

N2 - The dopamine hypothesis has been the cornerstone in the research and clinical practice of schizophrenia. With the initial emphasis on the role of excessive dopamine, the hypothesis has evolved to a concept of combining prefrontal hypodopaminergia and striatal hyperdopaminergia, and subsequently to the present aberrant salience hypothesis. This article provides a brief overview of the development and evidence of the dopamine hypothesis. It will argue that the current model of aberrant salience explains psychosis in schizophrenia and provides a plausible linkage between the pharmacological and cognitive aspects of the disease. Despite the privileged role of dopamine hypothesis in psychosis, its pathophysiological rather than etiological basis, its limitations in defining symptoms other than psychosis, as well as the evidence of other neurotransmitters such as glutamate and adenosine, prompt us to a wider perspective of the disease. Finally, dopamine does explain the pathophysiology of schizophrenia, but not necessarily the cause per se. Rather, dopamine acts as the common final pathway of a wide variety of predisposing factors, either environmental, genetic, or both, that lead to the disease. Other neurotransmitters, such as glutamate and adenosine, may also collaborate with dopamine to give rise to the entire picture of schizophrenia.

AB - The dopamine hypothesis has been the cornerstone in the research and clinical practice of schizophrenia. With the initial emphasis on the role of excessive dopamine, the hypothesis has evolved to a concept of combining prefrontal hypodopaminergia and striatal hyperdopaminergia, and subsequently to the present aberrant salience hypothesis. This article provides a brief overview of the development and evidence of the dopamine hypothesis. It will argue that the current model of aberrant salience explains psychosis in schizophrenia and provides a plausible linkage between the pharmacological and cognitive aspects of the disease. Despite the privileged role of dopamine hypothesis in psychosis, its pathophysiological rather than etiological basis, its limitations in defining symptoms other than psychosis, as well as the evidence of other neurotransmitters such as glutamate and adenosine, prompt us to a wider perspective of the disease. Finally, dopamine does explain the pathophysiology of schizophrenia, but not necessarily the cause per se. Rather, dopamine acts as the common final pathway of a wide variety of predisposing factors, either environmental, genetic, or both, that lead to the disease. Other neurotransmitters, such as glutamate and adenosine, may also collaborate with dopamine to give rise to the entire picture of schizophrenia.

KW - Aberrant salience

KW - Dopamine

KW - Dopamine hypothesis

KW - Psychosis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84888148750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888148750&partnerID=8YFLogxK

U2 - 10.1515/revneuro-2013-0011

DO - 10.1515/revneuro-2013-0011

M3 - Article

C2 - 23843581

AN - SCOPUS:84888148750

VL - 24

SP - 389

EP - 400

JO - Reviews in the Neurosciences

JF - Reviews in the Neurosciences

SN - 0334-1763

IS - 4

ER -